Home
Categories
EXPLORE
Comedy
True Crime
Society & Culture
History
Business
News
Sports
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts112/v4/d2/07/31/d20731e7-587a-2b82-d497-c39db83b5957/mza_10606593862519175967.png/600x600bb.jpg
JCO Precision Oncology Conversations
American Society of Clinical Oncology (ASCO)
57 episodes
6 days ago
JCO Precision Oncology Conversations is a monthly podcast featuring conversations with authors of clinically relevant and significant articles published in the JCO Precision Oncology journal. JCO Precision Oncology Conversations is hosted by the journal's social media editor, Dr. Abdul Rafeh Naqash.
Show more...
Medicine
Health & Fitness
RSS
All content for JCO Precision Oncology Conversations is the property of American Society of Clinical Oncology (ASCO) and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
JCO Precision Oncology Conversations is a monthly podcast featuring conversations with authors of clinically relevant and significant articles published in the JCO Precision Oncology journal. JCO Precision Oncology Conversations is hosted by the journal's social media editor, Dr. Abdul Rafeh Naqash.
Show more...
Medicine
Health & Fitness
https://is1-ssl.mzstatic.com/image/thumb/Podcasts112/v4/d2/07/31/d20731e7-587a-2b82-d497-c39db83b5957/mza_10606593862519175967.png/600x600bb.jpg
BRCA-Altered Uterine Sarcoma Treated with PARP Inhibitors
JCO Precision Oncology Conversations
24 minutes 56 seconds
3 months ago
BRCA-Altered Uterine Sarcoma Treated with PARP Inhibitors
JCO Precision Oncology Conversations
JCO Precision Oncology Conversations is a monthly podcast featuring conversations with authors of clinically relevant and significant articles published in the JCO Precision Oncology journal. JCO Precision Oncology Conversations is hosted by the journal's social media editor, Dr. Abdul Rafeh Naqash.